Source: International Congress 2015 – Developments in lung cancer diagnosis
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Francisco Sanz Herrero (Quart de Poblet (Valencia), Spain), Francisco Sanz, Enrique De Casimiro, Carmen María Cortés, Marisa Tárrega, Francisco Dasi, Estrella Fernández. Early detection of lung cancer in exhaled breath condensate using miRNA markers. Eur Respir J 2015; 46: Suppl. 59, 2998

Member's Comments

No comment yet.

Related content which might interest you: Proteomics and screening of lung cancer: Biomarkers selection by mass spectrometry and ELISA in the exhaled breath condensate (EBC) Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 The research on early detection of lung cancer with exhaled volatile organic compounds Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 Exhaled breath temperature in NSCLC: Could be a new non invasive marker? Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours Year: 2014 Volatile organic compounds of exhaled breath in lung cancer and lung inflammatory diseases Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Volatile organic compounds in exhaled breath samples as potential biomarkers in early diagnosis of lung cancer – (Ege translational pulmonology research group [EgeTPAG]) Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 Detection of lung cancer using expired breath analysis by ion mobility spectrometry Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Metabolomic analysis of serum samples from patients with lung cancer Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Metabolic signatures associated with lung cancer using serum samples. Influence of hemolysis Source: International Congress 2014 – Biology and pathology of thoracic tumours Year: 2014 Differences in volatile organic compounds (VOC) determined in exhaled breath in two populations of lung cancer (LC): With and without COPD Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Analysis of exhaled breath with electronic nose and diagnosis of lung cancer by support vector machine Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer Year: 2013 Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Automated target-FISH lung cancer detection (LCD) test of induced sputum Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Electronic nose as a screening tool for early stage lung cancer Source: International Congress 2014 – Improving diagnosis of thoracic tumours Year: 2014 Detection of early stage lung cancer by electronic nose Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours Year: 2014 Metabolic modification as a potential therapeutics approach in lung cancer Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013 Breath collection related factors may influence electronic nose ability to detect lung cancer Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Simultaneous EGFR and VEGF alterations in non-small cell lung carcinoma based on tissue microarrays Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014 Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014